These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27301119)

  • 61. Do young patients with dyspepsia need investigation?
    Williams B; Luckas M; Ellingham JH; Dain A; Wicks AC
    Lancet; 1988 Dec; 2(8624):1349-51. PubMed ID: 2904061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acid suppression therapy.
    Tavenor T
    Can J Gastroenterol; 1998; 12(5):320-1. PubMed ID: 9773209
    [No Abstract]   [Full Text] [Related]  

  • 63. Drug treatment of functional dyspepsia.
    Talley NJ
    Scand J Gastroenterol Suppl; 1991; 182():47-60. PubMed ID: 1896830
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
    Poen AC; Otten MH
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dyspepsia.
    Quigley EM; Keohane J
    Curr Opin Gastroenterol; 2008 Nov; 24(6):692-7. PubMed ID: 19122517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis and management of dyspepsia--clinical guideline, 1999. Dyspepsia Working Group, South African Medical Association, South African Gastroenterology Society Working Group.
    S Afr Med J; 1999 Aug; 89(8 Pt 2):897-903. PubMed ID: 10488367
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 68. Patient adherence to prescribed medication instructions for dyspepsia: the DIAMOND-study.
    Fransen GA; Mesters I; Muris JW; Van Marrewijk CJ; Mujakovic S; Laheij RJ; Numans ME; de Wit NJ; Samsom M; Jansen JB; Knottnerus JA
    Eur J Gen Pract; 2012 Jun; 18(2):79-85. PubMed ID: 22591059
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint.
    Waldum HL; Qvigstad G; Fossmark R; Kleveland PM; Sandvik AK
    Scand J Gastroenterol; 2010 Apr; 45(4):389-94. PubMed ID: 20001749
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Acid-related disorders].
    Bytzer P
    Ugeskr Laeger; 2008 Feb; 170(7):525-7. PubMed ID: 18291080
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
    Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Cystic polyposis of the stomach (fundic gland polyps)--relationship to the absence of Helicobacter pylori infection and a therapy with drugs suppressing gastric acidity].
    Fixa B; Vanásek T; Volfová M; Nozicka J; Nozicka Z
    Cas Lek Cesk; 2012; 151(4):196-200. PubMed ID: 22679686
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?
    Kinoshita Y; Ishihara S
    J Gastroenterol; 2004 Jan; 39(1):92-3. PubMed ID: 14767746
    [No Abstract]   [Full Text] [Related]  

  • 74. Can dietary integrators provide a clinical benefit in the treatment of functional dyspepsia? results from a prospective study with TUBES Gastro.
    Molteni M
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):105-12. PubMed ID: 24780944
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical economics review: functional (non-ulcer) dyspepsia.
    Tebaldi M; Heading RC
    Aliment Pharmacol Ther; 1998 Jan; 12(1):11-9. PubMed ID: 9692695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gastroduodenal motility.
    Tack J; Janssen P
    Curr Opin Gastroenterol; 2010 Nov; 26(6):647-55. PubMed ID: 20838344
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acid-suppressive medications during pregnancy and risk of asthma and allergy in the offspring: protocol for a systematic review.
    Devine RE; Sheikh A; Nwaru BI
    NPJ Prim Care Respir Med; 2016 Mar; 26():16001. PubMed ID: 26934831
    [No Abstract]   [Full Text] [Related]  

  • 78. [H2-blockers in the pediatric practice: is the potential exhausted?].
    Bel'mer SV; Kovalenko AA; Gasilina TV
    Eksp Klin Gastroenterol; 2005; (6):19-22. PubMed ID: 17378381
    [No Abstract]   [Full Text] [Related]  

  • 79. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Scheen AJ
    Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antacids in non-ulcer dyspepsia.
    Petersen H
    Scand J Gastroenterol Suppl; 1982; 75():77-8. PubMed ID: 6755654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.